Reducing severe gastrointestinal side effects, managing insulin sensitivity and hormonal balance, and improving cost efficiency for patients
Timing: PM
Frequency: Weekly
Protocol
Weeks 1-4: .25mg-.5mg
Uses
- Fewer Side Effects: Standard doses often cause nausea, vomiting, or severe fatigue. Lower doses may allow the body to adjust more gently, potentially increasing long-term compliance.
- Hormonal & Metabolic Balance: Lower doses may help manage blood sugar instability and insulin resistance, which is relevant for individuals with conditions like PCOS, without necessarily triggering rapid weight loss.
- Cost Efficiency & Flexibility: Using smaller amounts can extend the duration of a prescription, which is considered a cost-effective strategy for out-of-pocket payers or during medication shortages.
- Gradual Lifestyle Integration: It may avoid intense appetite aversion, potentially allowing for the development of sustainable eating habits alongside the medication
Benefits
- Significant weight loss and sustained weight management
- Reduced appetite and quieter food noise
- Improved blood sugar control and insulin sensitivity
- Improved cholesterol and triglyceride levels
- Modest blood pressure reduction
- Cardiovascular risk reduction demonstrated in brand-version trials
- Longer clinical track record than newer GLP-1 medications
Contraindications
Thyroid cancer history
- Personal history of medullary thyroid carcinoma
- Family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Pancreatic conditions
- History of pancreatitis
- Active gallbladder disease or gallstones
Gastrointestinal conditions
- Gastroparesis (delayed stomach emptying)
- Severe GERD or chronic vomiting
- Inflammatory bowel disease (flag for clinician review)
Eating disorders
- Bulimia (current or past)
- Anorexia Nervosa (current or past)
Pregnancy and fertility
- Currently pregnant
- Planning pregnancy in the near term
- Breastfeeding
Diabetes-specific cautions
- Type 1 diabetes
- History of diabetic retinopathy (flag for clinician review)
- Currently taking insulin or sulfonylureas (hypoglycemia risk, clinician must review)
Other
- Prior serious allergic reaction to semaglutide or tirzepatide
- Severe kidney disease (flag for clinician review)
- History of suicidal ideation (flag for clinician review)
Reducing severe gastrointestinal side effects, managing insulin sensitivity and hormonal balance, and improving cost efficiency for patients
Timing: PM
Frequency: Weekly
Protocol
Weeks 1-4: .25mg-.5mg
Uses
- Fewer Side Effects: Standard doses often cause nausea, vomiting, or severe fatigue. Lower doses may allow the body to adjust more gently, potentially increasing long-term compliance.
- Hormonal & Metabolic Balance: Lower doses may help manage blood sugar instability and insulin resistance, which is relevant for individuals with conditions like PCOS, without necessarily triggering rapid weight loss.
- Cost Efficiency & Flexibility: Using smaller amounts can extend the duration of a prescription, which is considered a cost-effective strategy for out-of-pocket payers or during medication shortages.
- Gradual Lifestyle Integration: It may avoid intense appetite aversion, potentially allowing for the development of sustainable eating habits alongside the medication
Benefits
- Significant weight loss and sustained weight management
- Reduced appetite and quieter food noise
- Improved blood sugar control and insulin sensitivity
- Improved cholesterol and triglyceride levels
- Modest blood pressure reduction
- Cardiovascular risk reduction demonstrated in brand-version trials
- Longer clinical track record than newer GLP-1 medications
Contraindications
Thyroid cancer history
- Personal history of medullary thyroid carcinoma
- Family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Pancreatic conditions
- History of pancreatitis
- Active gallbladder disease or gallstones
Gastrointestinal conditions
- Gastroparesis (delayed stomach emptying)
- Severe GERD or chronic vomiting
- Inflammatory bowel disease (flag for clinician review)
Eating disorders
- Bulimia (current or past)
- Anorexia Nervosa (current or past)
Pregnancy and fertility
- Currently pregnant
- Planning pregnancy in the near term
- Breastfeeding
Diabetes-specific cautions
- Type 1 diabetes
- History of diabetic retinopathy (flag for clinician review)
- Currently taking insulin or sulfonylureas (hypoglycemia risk, clinician must review)
Other
- Prior serious allergic reaction to semaglutide or tirzepatide
- Severe kidney disease (flag for clinician review)
- History of suicidal ideation (flag for clinician review)
Image 1 of 1